Kadcyla Halves Tumor Recurrence for Women With a Common Breast Cancer

WEDNESDAY, Dec. 5, 2018 — For certain women with early stage breast cancer, a newer drug that combines an antibody with chemotherapy may cut the risk of disease recurrence in half, a new trial finds.
The study focused on nearly 1,500 women with…
Source: Topamax